Lv1
58 积分 2025-02-05 加入
Assessment of Serum Bactericidal and Opsonophagocytic Activity of Antibodies to Gonococcal Vaccine Targets
2天前
已完结
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
2天前
已完结
The Lasting Impact of IL-2: Approaching 50 Years of Advancing Immune Tolerance, Cancer Immunotherapies, and Autoimmune Diseases
6天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
6天前
已完结
The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-α4β7Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
6天前
已完结
Discovery of Novel Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors for Cancer Treatment
30天前
已完结
The signaling pathways activated by ROR1 in cancer
1个月前
已完结
Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies
1个月前
已完结
GenSci120, a humanized PD-1 agonistic monoclonal antibody, enhances the binding of both PD-L1 and PD-L2 to PD-1, and mitigates the symptoms of GVHD in a mouse model
1个月前
已完结
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases
1个月前
已完结
皖公网安备34019202002308
